A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Completed · Phase 4 · Has a placebo group

Conditions studied: Bipolar Disorder

In brief

The purpose of this clinical research study is to learn if outpatients with bipolar mania who are partially nonresponsive to lithium or valproate monotherapy can achieve stable symptoms on a combination treatment of aripiprazole plus lithium or valproate.

Key facts

Study ID
NCT00261443
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
People needed
1270
Starts
2005-09-01
Expected to finish
2009-10-01
Last updated by the study team
2023-04-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.